Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

6 Nov 2014 07:00

RNS Number : 2805W
Wilmington Group Plc
06 November 2014
 



6 November 2014

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets, presents its Interim Management Statement for the period from 1 July 2014, based on the results for the three months ended 30 September 2014 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading Update

 

The Group has made a good start to the year with revenue up during the three months ended 30 September 2014 despite adverse currency effects. Our business is performing well against the comparative period in 2013 and in line with our expectations.

 

Banking & Compliance: ICT (compliance training) continues to secure major training programmes from international banks, and this has resulted in strong revenue growth during the three months ended 30 September 2014. As previously reported we have invested in additional resource to support the business' expansion, and despite this contribution to profits has grown strongly. AMT (banking training) which delivers most of its revenue and contribution during the summer months has again delivered revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in Hong Kong. This division does have significant international operations and has been adversely impacted by movements in exchange rates.

 

Pensions & Insurance: This division continues to deliver revenue and contribution growth and has maintained its high margins. ICP (company credit reporting), which had a record year last year, has seen a small fall in demand but has mitigated this to a large extent by good cost control. This division also has significant international operations and has therefore also been adversely impacted by movements in exchange rates year on year.

 

Healthcare: This division benefitted from a significant investment last year with five senior appointments which is reflected in a higher overhead base in the first quarter compared to the same period in 2013. We have seen positive overall revenue growth compared to the same period in the prior year despite the negative impact of the Euro on our French language medical news agency, Agence de Presse Médicale. It is too early to see if the challenging conditions have abated but we are encouraged by the good start to the year.

 

Legal: The Legal division has continued to experience challenging conditions although the rate of decline has moderated and some areas, particularly Bond Solon, continue to see growth. Our lower cost base has meant that the performance from the division has improved compared to the same period in 2013.

 

Business Intelligence: As anticipated, revenue is up slightly on the same period in 2013. This combined with a lower cost base resulted in contribution in line with our expectations and up on the same period in 2013.

 

Accountancy: The division has enjoyed a strong start to the year reflecting inter alia demand for face to face public course training. This additional revenue is reflected in the division's pleasing overall increase in contribution due to the operational gearing of the business.

 

Management

As previously announced, Pedro Ros assumed the role of Chief Executive on 1 October 2014 having joined the Board on 14 July 2014.

Net Debt

The Group's cash position remains robust benefitting from strong operational cashflows. Net debt as at 30 September 2014 was £32.6m (30 September 2013: £39.2m).

 

Outlook

The overall trading background has not changed significantly since the full year 2014 results announcement and the business is on track to meet our expectations for the full year.

We are progressing well on our review of the businesses and expect to provide an update during December 2014.

 

 

-End-

 

 

 

For further information, please contact:

Wilmington Group plc

020 7422 6800

Pedro Ros, Chief Executive

Tony Foye, Chief Finance Officer

FTI Consulting

020 3727 1000

Charles Palmer / Emma Appleton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGRCGUPCGMA
Date   Source Headline
1st Mar 20171:58 pmRNSVoting Rights and Capital
24th Feb 20172:29 pmRNSDirector/PDMR Shareholding
23rd Feb 20179:36 amRNSInterim Results - Update
23rd Feb 20177:00 amRNSInterim Results
1st Feb 20171:10 pmRNSVoting Rights and Capital
1st Feb 20177:00 amRNSCompletion of Health Service Journal
19th Jan 20177:04 amRNSAcquisition of Health Service Journal
18th Jan 20175:08 pmRNSHolding(s) in Company
17th Jan 20174:43 pmRNSHolding(s) in Company
12th Jan 20179:00 amRNSNotice of Interim Results
3rd Jan 201712:20 pmRNSTotal Voting Rights and Capital
16th Dec 20163:22 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSVoting Rights and Capital
3rd Nov 20164:03 pmRNSResult of AGM
3rd Nov 20167:00 amRNSAGM and Q1 Trading update
1st Nov 20167:00 amRNSVoting Rights and Capital
17th Oct 201612:53 pmRNSHolding(s) in Company
3rd Oct 201610:05 amRNSVoting Rights and Capital
21st Sep 20162:48 pmRNSDirector/PDMR Shareholdings
20th Sep 201611:54 amRNSShare Awards
16th Sep 20164:31 pmRNSReplacement: Share Awards and Options
16th Sep 20169:10 amRNSShare Awards and Options
14th Sep 20167:00 amRNSFinal Results
2nd Sep 20161:48 pmRNSHolding(s) in Company
1st Sep 20169:39 amRNSVoting Rights and Capital
11th Aug 201610:31 amRNSNotice of Final Results
1st Aug 20169:44 amRNSVoting Rights and Capital
21st Jul 20169:41 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSAcquisition of SWAT
1st Jul 20167:00 amRNSVoting Rights and Capital
10th Jun 20165:04 pmRNSHolding(s) in Company
1st Jun 201611:55 amRNSVoting Rights and Capital
23rd May 201611:57 amRNSHolding(s) in Company
12th May 20167:00 amRNSInterim Management Statement
4th May 20164:05 pmRNSHolding(s) in Company
4th May 20163:54 pmRNSHolding(s) in Company
3rd May 201610:03 amRNSTotal Voting Rights
29th Apr 20169:33 amRNSChange of Company Secretary
1st Apr 20169:33 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAcquisition
18th Mar 20163:10 pmRNSHolding(s) in Company
11th Mar 20162:03 pmRNSDirector/PDMR Shareholding
1st Mar 20164:37 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSInterim Results
1st Feb 20169:37 amRNSTotal Voting Rights
19th Jan 20167:00 amRNSAcquisition
15th Jan 20169:52 amRNSHolding(s) in Company
12th Jan 201610:54 amRNSNotification of Interim Results
4th Jan 201611:12 amRNSTotal Voting Rights
17th Dec 20157:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.